NEXGEL, INC. NXGLW
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
-6.91
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $11.4M | -$3.0M | $4.5M | -$1.4M | $4.9M |
| 2024 | $8.7M | -$3.3M | $2.7M | -$4.3M | $6.1M |
| 2023 | $4.1M | -$3.2M | $374,000 | -$3.9M | $5.2M |
| 2022 | $2.0M | -$4.7M | $256,000 | -$3.1M | $7.6M |
| 2021 | $1.6M | -$4.3M | $8,000 | -$3.0M | $12.1M |
| 2020 | $674,000 | -$2.3M | -$291,000 | -$2.1M | $71,000 |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer | 2026-06-23 | Sell | 5,000 | $0.59 |
| Levy Adam R. | Chief Executive Officer | 2026-06-18 | Sell | 6,000 | $0.59 |
| Levy Adam R. | Chief Executive Officer | 2026-06-11 | Sell | 3,000 | $0.61 |
| Levy Adam R. | Chief Executive Officer | 2026-06-08 | Sell | 3,000 | $0.55 |
| Levy Adam R. | Chief Executive Officer | 2026-06-04 | Sell | 3,000 | $0.59 |
| Levy Adam R. | Chief Executive Officer | 2026-06-01 | Sell | 2,000 | $0.59 |
| Levy Adam R. | Chief Executive Officer | 2026-05-29 | Sell | 3,000 | $0.60 |
| Levy Adam R. | Chief Executive Officer | 2026-05-28 | Sell | 7,000 | $0.61 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.91 (distress)
- Working capital / assets 0.132
- Retained earnings / assets -2.007
- EBIT / assets -0.32
- Equity / liabilities 0.878
Source: SEC EDGAR filings · CIK 0001468929 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.